Bensen Daniel
Related Filers (1)
Other (4)
144
Monday, 2/12/2024
Filing for proposed sale of securities under Rule 144
144
Tuesday, 2/6/2024
Filing for proposed sale of securities under Rule 144
144
Friday, 2/2/2024
Filing for proposed sale of securities under Rule 144
144
Friday, 6/23/2023
Filing for proposed sale of securities under Rule 144
Ownership (17)
4
Wednesday, 2/14/2024
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/9/2024
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/6/2024
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/1/2023
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/21/2023
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/17/2023
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/12/2023
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/3/2023
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/28/2023
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/15/2023
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/3/2023
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/29/2023
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/23/2023
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/8/2022
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/4/2021
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/17/2021
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 9/14/2021
Tyra Biosciences, Inc.: Initial statement of beneficial ownership of securities